✦ LIBER ✦

Feasibility study of paclitaxel plus carboplatin in patients with endometrial cancer: A Japan Kanto Tumor Board study (JKTB trial)

✍ Scribed by Kyosuke Yamada; Hiroshi Tanabe; Manami Imai; Toshiko Jobo; Kazuya Kudo; Hiroyuki Fujiwara; Chie Nagata; Kenichi Furuya; Mitsuaki Suzuki; Kazunori Ochiai; Tadao Tanaka; Makoto Yasuda

Book ID: 119845163
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 110 KB
Volume: 39
Category: Article
ISSN: 1341-8076
DOI: 10.1111/j.1447-0756.2012.01890.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A feasibility study of carboplatin and w

A feasibility study of carboplatin and weekly paclitaxel combination chemotherapy in endometrial cancer: A Kansai Clinical Oncology Group study (KCOG0015 trial)

✍ Kimihiko Ito; Hiroshi Tsubamoto; Yoshio Itani; Haruo Kuroboshi; Hiroyuki Fujita; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Phase 1A/B study of combination carbopla

Phase 1A/B study of combination carboplatin, paclitaxel and ridaforolim- us in patients with solid, endometrial, and ovarian cancers

✍ Chon, H.; Herschberger, A.; Lee, J.; Wenham, R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Phase I feasibility trial of carboplatin

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Paclitaxel and carboplatin in the adjuva

Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: A retrospective study

✍ Mika A. Sovak; Martee L. Hensley; Jakob Dupont; Nicole Ishill; Kaled M. Alektiar 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Phase II study of carboplatin in patient

Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group

✍ F.H van Wijk; C Lhommé; G Bolis; V Scotto di Palumbo; S Tumolo; M Nooij; C.F de 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 139 KB

A phase I trial of dose-dense (biweekly)

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: A Gynecologic Oncology Group study

✍ Amy D. Tiersten; Michael W. Sill; Danielle Knight; Franco Muggia; Agustin A. Gar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 226 KB